142 related articles for article (PubMed ID: 8780522)
41. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
[TBL] [Abstract][Full Text] [Related]
42. Abortive transcription of the T7 promoter induced by elsamicin A.
Portugal J
Anticancer Drug Des; 1995 Jul; 10(5):427-38. PubMed ID: 7639931
[TBL] [Abstract][Full Text] [Related]
43. Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.
Klemm M; Cheng C; Cassell G; Shuman S; Segall AM
J Mol Biol; 2000 Jun; 299(5):1203-16. PubMed ID: 10873446
[TBL] [Abstract][Full Text] [Related]
44. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
45. A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.
Hecht SM; Berry DE; MacKenzie LJ; Busby RW; Nasuti CA
J Nat Prod; 1992 Apr; 55(4):401-13. PubMed ID: 1324981
[TBL] [Abstract][Full Text] [Related]
46. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
47. Transition protein 4 from boar late spermatid nuclei is a topological factor that stimulates DNA-relaxing activity of topoisomerase I.
Akama K; Kondo M; Sato H; Nakano M
FEBS Lett; 1999 Jan; 442(2-3):189-92. PubMed ID: 9928999
[TBL] [Abstract][Full Text] [Related]
48. Vaccinia DNA topoisomerase I: evidence supporting a free rotation mechanism for DNA supercoil relaxation.
Stivers JT; Harris TK; Mildvan AS
Biochemistry; 1997 Apr; 36(17):5212-22. PubMed ID: 9136883
[TBL] [Abstract][Full Text] [Related]
49. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
[TBL] [Abstract][Full Text] [Related]
50. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
Hammonds TR; Foster SR; Maxwell A
J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
[TBL] [Abstract][Full Text] [Related]
51. DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators.
Pommier Y; Covey JM; Kerrigan D; Markovits J; Pham R
Nucleic Acids Res; 1987 Aug; 15(16):6713-31. PubMed ID: 2819825
[TBL] [Abstract][Full Text] [Related]
52. A rapid method for the measurement of the unwinding angle of intercalating agents and the superhelix density of circular DNAs.
Lee JS; Morgan AR
Nucleic Acids Res; 1978 Jul; 5(7):2425-39. PubMed ID: 209409
[TBL] [Abstract][Full Text] [Related]
53. Molecular dynamics study of the binding of elsamicin A to DNA.
Alhambra C; Luque FJ; Portugal J; Orozco M
Eur J Biochem; 1995 Jun; 230(2):555-66. PubMed ID: 7607229
[TBL] [Abstract][Full Text] [Related]
54. Ribonuclease activity of vaccinia DNA topoisomerase IB: kinetic and high-throughput inhibition studies using a robust continuous fluorescence assay.
Kwon K; Nagarajan R; Stivers JT
Biochemistry; 2004 Nov; 43(47):14994-5004. PubMed ID: 15554707
[TBL] [Abstract][Full Text] [Related]
55. DNA interaction and dual topoisomerase I and II inhibition properties of the anti-tumor drug prodigiosin.
Montaner B; Castillo-Avila W; Martinell M; Ollinger R; Aymami J; Giralt E; Pérez-Tomás R
Toxicol Sci; 2005 Jun; 85(2):870-9. PubMed ID: 15788728
[TBL] [Abstract][Full Text] [Related]
56. Antitumour drugs impede DNA uncoiling by topoisomerase I.
Koster DA; Palle K; Bot ES; Bjornsti MA; Dekker NH
Nature; 2007 Jul; 448(7150):213-7. PubMed ID: 17589503
[TBL] [Abstract][Full Text] [Related]
57. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
[TBL] [Abstract][Full Text] [Related]
58. Topoisomerase assays.
Nitiss JL; Soans E; Rogojina A; Seth A; Mishina M
Curr Protoc Pharmacol; 2012 Jun; Chapter 3():Unit 3.3.. PubMed ID: 22684721
[TBL] [Abstract][Full Text] [Related]
59. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I.
Covey JM; Jaxel C; Kohn KW; Pommier Y
Cancer Res; 1989 Sep; 49(18):5016-22. PubMed ID: 2548707
[TBL] [Abstract][Full Text] [Related]
60. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
Barret JM; Calsou P; Larsen AK; Salles B
Mol Pharmacol; 1994 Sep; 46(3):431-6. PubMed ID: 7935322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
